|
CN111721849A
|
|
Analysis method for determining content of main drug in pramipexole dihydrochloride sustained-release tablets
|
|
CN107802606A
|
|
A kind of injection Carfilzomib and preparation method thereof
|
|
CN107961224A
|
|
A kind of pazopanib piece and preparation method thereof
|
|
CN104721155A
|
|
Temozolomide lyophilized powder preparation and preparation method thereof
|
|
CN104706650A
|
|
Azacitidine freeze-dried preparation and preparation method thereof
|
|
CN103845332A
|
|
Medicinal dasatinib composition and preparation method thereof
|
|
CN103784411A
|
|
Erlotinib hydrochloride medicinal composition and preparation method thereof
|
|
CN102688185A
|
|
Stable palonosetron injection and preparation method thereof
|
|
CN103356488A
|
|
Capecitabine granule and preparation method thereof
|
|
CN102614183A
|
|
Oral preparation containing tegafur, gimeracil and oteracil potassium
|
|
CN102319222A
|
|
Decitabine freeze-dried preparation and preparation method thereof
|
|
CN102276467B
|
|
Preparation method of 2-aryl-pentyne-4-olic acid ester compounds
|
|
CN102406603A
|
|
Supersaturated solution with stable gemcitabine hydrochloride and preparation method thereof
|
